If You Missed The National Allergy Meeting Last Year, See Key Points of Study Results Presented!

Efficacy & Safety of Intranasal Corticosteroids Approved for Over-the-Counter Use: Allergic rhinitis (AR) affects 20%-25% of Canadians. Clinical evidence indicates that INCSs are the most effective class of medications currently available for the treatment of AR demonstrating superior efficacy in reducing total nasal symptom scores and nasal blockage. ARIA (Allergic Rhinitis and its Impact on Asthma) & Canadian Guidelines recommend the use of INCSs to manage mild persistent to moderate-severe allergic rhinitis. Read more

Association Between Mental Health and Heart Health

Preliminary results presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018 indicate that depression may increase the risk of atrial fibrillation. Participants who scored highest on clinical depression screening and those taking antidepressants were shown to have a more than 30% higher risk of developing atrial fibrillation than those with normal test scores and not taking medication for depression. Untreated atrial fibrillation doubles the risk of heart-related death and is associated with a five-fold increased risk of stroke. American Heart Association^®
Read more

BMI as a Predictor of CVD Risk

Research has long suggested that higher BMI is associated with an increased risk of cardiovascular disease (CVD). In this recent study, researchers investigated the potential bias associated with assessing risk based on BMI, which may be affected by pre-existing comorbidities, versus adiposity measures. European Heart Journal
Read more

Midlife Cardiovascular Fitness and Risk of Dementia

In a population of women assessed periodically for up to 44 years, high cardiovascular fitness at midlife was associated with a reduced risk of subsequent dementia. High compared with medium fitness decreased the risk of dementia by 88%. The study suggests that adverse cardiovascular processes may be occurring in midlife that appear to increase the risk for dementia. Neurology^®
Read more

Simplified Guideline for Prescribing Medical Cannabinoids in Primary Care

February 2018, Canadian Family Physician

Management of Opioid Use Disorders: A National Clinical Practice Guideline

March 2018, Canadian Medical Association Journal

2018 Guidelines for the Management of Patients with Bipolar Disorder

March 2018, Bipolar Disorders - An International Journal of Psychiatry and Neurosciences

How Generic Medicines are Helping Reshape Attention Deficit Hyperactivity Disorder (ADHD) Management

One-hour live presentation + half-hour interactive Q&A

Friday, April 6, 9:00 AM EDT | Friday, April 6, 12:00 PM EDT
Monday, April 9, 8:00 PM EDT | Wednesday, April 11, 5:00 PM EDT
Registration